• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Trending

Pinned News

FDA approves Roche’s Lunsumio VELO for subcutaneous use in relapsed or refractory follicular lymphoma

Event Tracking

Dec22
FDA Approves Roche's Lunsumio VELO for Lymphoma Treatment
06:00
Dec20
Roche CEO Warns US Drug Price Cuts Could Impact Swiss Prices
21:35
Dec19
Genentech Reaches Agreement with US Government to Lower Medicaid Plan Costs
19:52
Roche Holding to Invest $50 Billion to Expand Manufacturing and R&D in the US
19:28
Dec17
Novartis and Roche Near Deal on US Drug Prices
18:02
Novartis and Roche Near Deal in Drug Pricing Talks with White House
17:54

Schedules & Filings

Schedules
Filings
Jan29
Earning Release(EST)

FY2025 Annual Earning Release

Jul24
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 19.91 B, Net Income 4.632 B, EPS 0.7212

Mar28
Distribution Plan(EST)

Cash dividend 1.3629 USD

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
LAZR
0.6044
+174.73%
+0.384
NBY
5.300
+79.66%
+2.350
MIMI
0.4795
+75.45%
+0.206
AZI
2.500
+64.47%
+0.980
GDC
5.260
+51.59%
+1.790
SOS
2.200
+47.65%
+0.710
IBO
0.6491
+46.26%
+0.205
FLYT
17.130
+45.42%
+5.350
CRWG
3.950
+45.22%
+1.230
CRWU
7.290
+44.93%
+2.260
View More